Status:
COMPLETED
Brief Cognitive Behavioral Therapy for Anxiety
Lead Sponsor:
Michael E. DeBakey VA Medical Center
Conditions:
Anxiety
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The proposed clinical intervention is a modular skills-based intervention for flexible delivery of care, measurement-based care practices, and integration of exposure strategies critical for anxiety s...
Detailed Description
Anxiety disorders are identified in over 30% of primary care patients and are associated with substantial functional impairment, poor health-related quality of life, and suicide; however, rates of tre...
Eligibility Criteria
Inclusion
- Veteran participants: The sample will include Veterans who:
- receive care at the Houston VA and surrounding area CBOCs,
- have documentation in the medical chart of an anxiety disorder or anxiety-related problems, and
- report clinically significant symptoms of anxiety, defined as a score of 10 or greater on the Generalized Anxiety Disorder Scale, 7th edition (GAD-7).
Exclusion
- Veteran participants will be excluded for factors that would render bCBT inappropriate, including:
- cognitive impairment;
- presence of bipolar, psychotic or substance use disorders, and
- Veteran is currently receiving psychotherapy for anxiety. If receiving medications that target anxiety Veterans WILL NOT be excluded.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03820973
Start Date
February 1 2019
End Date
September 1 2021
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michael E. DeBakey VAMC
Houston, Texas, United States, 77030